Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M113,178Revenue (TTM) $M32,839Net Margin (%)52.8Altman Z-Score4.7
Enterprise Value $M128,301EPS (TTM) $11.7Operating Margin %65.4Piotroski F-Score5
P/E(ttm)7.3Beneish M-Score-2.4Pre-tax Margin (%)63.7Higher ROA y-yN
Price/Book8.610-y EBITDA Growth Rate %--Quick Ratio1.6Cash flow > EarningsY
Price/Sales3.85-y EBITDA Growth Rate %45.9Current Ratio1.8Lower Leverage y-yN
Price/Free Cash Flow7.2y-y EBITDA Growth Rate %32.4ROA % (ttm)38.1Higher Current Ratio y-yN
Dividend Yield %2.1PEG0.2ROE % (ttm)105Less Shares Outstanding y-yY
Payout Ratio %15.0Shares Outstanding M1,332ROIC % (ttm)76.6Gross Margin Increase y-yY

Gurus Latest Trades with GILD

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GILDJulian Robertson 2016-03-31 Reduce-4.65%$82.71 - $101.19
($90.37)
$ 84.71-6%Reduce -90.24%38,511
GILDLeon Cooperman 2016-03-31 Buy 1.26%$82.71 - $101.19
($90.37)
$ 84.71-6%New holding516,989
GILDDavid Dreman 2016-03-31 Buy 0.24%$82.71 - $101.19
($90.37)
$ 84.71-6%New holding23,210
GILDJoel Greenblatt 2016-03-31 Add0.1%$82.71 - $101.19
($90.37)
$ 84.71-6%Add 10.68%967,642
GILDNWQ Managers 2016-03-31 Reduce-0.08%$82.71 - $101.19
($90.37)
$ 84.71-6%Reduce -30.50%116,000
GILDJohn Rogers 2016-03-31 Add0.05%$82.71 - $101.19
($90.37)
$ 84.71-6%Add 3.58%1,360,492
GILDT Rowe Price Equity Income Fund 2016-03-31 Add0.04%$82.71 - $101.19
($90.37)
$ 84.71-6%Add 8.29%1,353,600
GILDKen Fisher 2016-03-31 Reduce-0.01%$82.71 - $101.19
($90.37)
$ 84.71-6%Reduce -13.63%487,030
GILDGeorge Soros 2016-03-31 Buy 0.01%$82.71 - $101.19
($90.37)
$ 84.71-6%New holding3,600
GILDMario Gabelli 2016-03-31 Reduce$82.71 - $101.19
($90.37)
$ 84.71-6%Reduce -4.71%40,690
GILDRonald Muhlenkamp 2016-03-31 Add$82.71 - $101.19
($90.37)
$ 84.71-6%Add 0.01%217,990
GILDFirst Eagle Investment 2016-03-31 Add$82.71 - $101.19
($90.37)
$ 84.71-6%Add 2200.00%9,200
GILDDodge & Cox 2016-03-31 Add$82.71 - $101.19
($90.37)
$ 84.71-6%Add 103.20%7,620
GILDT Rowe Price Equity Income Fund 2015-12-31 Buy 0.57%$97.54 - $110.96
($104.15)
$ 84.71-19%New holding1,250,000
GILDJulian Robertson 2015-12-31 Add0.55%$97.54 - $110.96
($104.19)
$ 84.71-19%Add 11.95%394,411
GILDDavid Dreman 2015-12-31 Sold Out -0.11%$97.54 - $110.96
($104.19)
$ 84.71-19%Sold Out0
GILDJohn Keeley 2015-12-31 Sold Out -0.08%$97.54 - $110.96
($104.19)
$ 84.71-19%Sold Out0
GILDJoel Greenblatt 2015-12-31 Reduce-0.06%$97.54 - $110.96
($104.19)
$ 84.71-19%Reduce -6.70%874,246
GILDDodge & Cox 2015-12-31 Reduce$97.54 - $110.96
($104.19)
$ 84.71-19%Reduce -11.76%3,750
GILDKen Fisher 2015-12-31 Add$97.54 - $110.96
($104.15)
$ 84.71-19%Add 0.27%563,917
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GILD is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


GILD: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MILLIGAN JOHN FPresident and CEO 2016-06-06Sell112,000$86.94-2.56view
MARTIN JOHN CExecutive Chairman 2016-06-01Sell100,000$86.72-2.32view
Carter Paul RutherfordEVP Commercial Ops 2016-06-01Sell2,000$87.02-2.65view
Carter Paul RutherfordEVP Commercial Ops 2016-05-31Sell57,092$86.85-2.46view
MILLIGAN JOHN FPresident and CEO 2016-05-02Sell112,000$87.71-3.42view
MARTIN JOHN CExecutive Chairman 2016-05-02Sell100,000$87.82-3.54view
Carter Paul RutherfordEVP Commercial Ops 2016-05-02Sell2,000$88.72-4.52view
Alton Gregg HEVP, Corp & Med Affairs 2016-04-19Sell40,000$100.01-15.3view
MILLIGAN JOHN FPresident and CEO 2016-04-04Sell112,000$94.59-10.45view
Carter Paul RutherfordEVP Commercial Ops 2016-04-01Sell2,000$91.34-7.26view

Quarterly/Annual Reports about GILD:

News about GILD:

Articles On GuruFocus.com
Stocks Have Record Quarter for Share Buybacks Jun 22 2016 
GuruFocus Best Idea Contest 2016: Who Is Beating the Market Jun 05 2016 
Wall Street Estimates and Biopharma Value Investing Jun 02 2016 
Gilead and Celgene Among Biotechnology Stocks to Buy May 26 2016 
Endonovo Therapeutics: Innovative Treatment, Catalyst Create Compelling Opportunity May 22 2016 
Gilead Sciences Appears to Have Bottomed: Time to Buy? May 20 2016 
Is Seasonal Investing the Best Way to Approach the Market? May 13 2016 
John Buckingham Touts Apple, Gilead, Amgen May 11 2016 
The PBM Empire Strikes Back May 10 2016 
There Are Many Reasons to be Optimistic About Gilead's Prospects May 03 2016 

More From Other Websites
State lowers requirements for MassHealth patients to get hepatitis C drugs Jul 01 2016
Gilead Sciences: Going Up? Jul 01 2016
We've Traded This Stock 11 Times For Income. Let's Do It Again... Jul 01 2016
The C-Suite Speaks: Healthy Consumers Jul 01 2016
3 Potential Stock-Moving Drug Events In The Second Half Of 2016 Jul 01 2016
Cramer Remix: Short-sellers have woken up to their worst ... Jun 30 2016
The 4 Best biotech trades right now Jun 30 2016
David Harding of Winton Capital Made Huge Gains on Brexit despite Backing the Remain Campaign Jun 30 2016
The Zacks Analyst Blog Highlights: Gilead, Regulus, AbbVie, The Medicines and GW Pharma Jun 30 2016
Bill Gates Calls U.S. Drug Pricing System ‘Better Than Most’ Jun 30 2016
Bill Gates Calls U.S. Drug Pricing System ‘Better Than Most’ Jun 30 2016
This Biotech’s Stock Just Doubled and It’s Bad News for Sanofi Jun 29 2016
The First-Ever Drug to Treat All Major Hep C Strains Just Got Approved Jun 29 2016
Top 6 Research Reports for June 29, 2016 Jun 29 2016
Biotech Stock Roundup: Gilead Gets FDA Nod for HCV Drug, Regulus Hit by Clinical Hold Jun 29 2016
Gilead Reverses Price Course Jun 29 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)